title: Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin-angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20).
authors.affiliation: Medizinische Klinik III der Universität zu Köln, Köln, Germany. erland.erdmann@uni-koeln.de
authors.forename: Erland
authors.initials: E
authors.lastname: Erdmann
authors.forename: Robert
authors.initials: R
authors.lastname: Spanheimer
authors.forename: Bernard
authors.initials: B
authors.lastname: Charbonnel